ミズホメディーの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/01/23 | 1,434 | 1,435 | 1,413 | 1,414 | -20 | -1.4% | 192,400 |
| 2025/01/22 | 1,446 | 1,458 | 1,430 | 1,434 | -8 | -0.6% | 122,800 |
| 2025/01/21 | 1,455 | 1,455 | 1,433 | 1,442 | -6 | -0.4% | 140,700 |
| 2025/01/20 | 1,451 | 1,453 | 1,443 | 1,448 | -1 | -0.1% | 72,700 |
| 2025/01/17 | 1,475 | 1,475 | 1,444 | 1,449 | -23 | -1.6% | 161,100 |
| 2025/01/16 | 1,497 | 1,507 | 1,472 | 1,472 | -24 | -1.6% | 111,000 |
| 2025/01/15 | 1,513 | 1,516 | 1,490 | 1,496 | -19 | -1.3% | 126,600 |
| 2025/01/14 | 1,547 | 1,550 | 1,498 | 1,515 | -27 | -1.8% | 265,500 |
| 2025/01/10 | 1,495 | 1,545 | 1,487 | 1,542 | +42 | +2.8% | 412,100 |
| 2025/01/09 | 1,515 | 1,531 | 1,482 | 1,500 | -5 | -0.3% | 254,200 |
| 2025/01/08 | 1,478 | 1,509 | 1,477 | 1,505 | +40 | +2.7% | 223,500 |
| 2025/01/07 | 1,472 | 1,482 | 1,464 | 1,465 | -6 | -0.4% | 141,900 |
| 2025/01/06 | 1,501 | 1,505 | 1,469 | 1,471 | -30 | -2% | 209,700 |
| 2024/12/30 | 1,509 | 1,518 | 1,499 | 1,501 | -10 | -0.7% | 318,600 |
| 2024/12/27 | 1,489 | 1,512 | 1,481 | 1,511 | -7 | -0.5% | 346,300 |
| 2024/12/26 | 1,480 | 1,525 | 1,477 | 1,518 | +45 | +3.1% | 333,800 |
| 2024/12/25 | 1,486 | 1,488 | 1,465 | 1,473 | -13 | -0.9% | 196,500 |
| 2024/12/24 | 1,489 | 1,499 | 1,483 | 1,486 | +7 | +0.5% | 139,600 |
| 2024/12/23 | 1,474 | 1,480 | 1,465 | 1,479 | +2 | +0.1% | 248,400 |
| 2024/12/20 | 1,480 | 1,487 | 1,476 | 1,477 | -7 | -0.5% | 240,600 |
| 2024/12/19 | 1,482 | 1,489 | 1,475 | 1,484 | -5 | -0.3% | 142,000 |
| 2024/12/18 | 1,501 | 1,501 | 1,481 | 1,489 | -11 | -0.7% | 249,100 |
| 2024/12/17 | 1,503 | 1,514 | 1,500 | 1,500 | -12 | -0.8% | 298,400 |
| 2024/12/16 | 1,533 | 1,533 | 1,512 | 1,512 | -23 | -1.5% | 154,600 |
| 2024/12/13 | 1,530 | 1,547 | 1,529 | 1,535 | -2 | -0.1% | 163,900 |
| 2024/12/12 | 1,540 | 1,546 | 1,533 | 1,537 | -9 | -0.6% | 172,500 |
| 2024/12/11 | 1,530 | 1,552 | 1,521 | 1,546 | +22 | +1.4% | 123,900 |
| 2024/12/10 | 1,549 | 1,549 | 1,523 | 1,524 | -1 | -0.1% | 241,200 |
| 2024/12/09 | 1,532 | 1,541 | 1,525 | 1,525 | -30 | -1.9% | 264,900 |
| 2024/12/06 | 1,550 | 1,560 | 1,547 | 1,555 | -1 | -0.1% | 81,200 |
| 2024/12/05 | 1,570 | 1,570 | 1,556 | 1,556 | -13 | -0.8% | 129,000 |
| 2024/12/04 | 1,618 | 1,619 | 1,569 | 1,569 | -11 | -0.7% | 119,200 |
| 2024/12/03 | 1,580 | 1,593 | 1,571 | 1,580 | -6 | -0.4% | 85,700 |
| 2024/12/02 | 1,602 | 1,602 | 1,573 | 1,586 | -7 | -0.4% | 65,000 |
| 2024/11/29 | 1,585 | 1,605 | 1,583 | 1,593 | +16 | +1% | 53,400 |
| 2024/11/28 | 1,561 | 1,591 | 1,561 | 1,577 | -16 | -1% | 111,200 |
| 2024/11/27 | 1,622 | 1,622 | 1,585 | 1,593 | -38 | -2.3% | 123,400 |
| 2024/11/26 | 1,612 | 1,643 | 1,603 | 1,631 | -8 | -0.5% | 62,500 |
| 2024/11/25 | 1,634 | 1,645 | 1,630 | 1,639 | +9 | +0.6% | 30,100 |
| 2024/11/22 | 1,620 | 1,632 | 1,616 | 1,630 | +10 | +0.6% | 19,800 |
| 2024/11/21 | 1,630 | 1,630 | 1,619 | 1,620 | -10 | -0.6% | 20,300 |
| 2024/11/20 | 1,624 | 1,630 | 1,617 | 1,630 | +6 | +0.4% | 35,000 |
| 2024/11/19 | 1,617 | 1,628 | 1,617 | 1,624 | +7 | +0.4% | 11,800 |
| 2024/11/18 | 1,618 | 1,629 | 1,616 | 1,617 | ±0 | ±0% | 17,700 |
| 2024/11/15 | 1,624 | 1,627 | 1,617 | 1,617 | +5 | +0.3% | 12,700 |
| 2024/11/14 | 1,640 | 1,640 | 1,612 | 1,612 | -21 | -1.3% | 57,600 |
| 2024/11/13 | 1,653 | 1,659 | 1,633 | 1,633 | -19 | -1.2% | 57,100 |
| 2024/11/12 | 1,639 | 1,655 | 1,639 | 1,652 | +21 | +1.3% | 29,400 |
| 2024/11/11 | 1,612 | 1,643 | 1,612 | 1,631 | +5 | +0.3% | 41,500 |
| 2024/11/08 | 1,648 | 1,651 | 1,611 | 1,626 | -6 | -0.4% | 60,800 |
51～
100
件表示中 / 2272件
類似銘柄と比較する
現在ご覧いただいている「ミズホメディ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ミズホメディ | 140,100円 | +1.2% | -13.9% | 6.07% | 8.26倍 | 1.54倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| ダイト | 206,800円 | +4.5% | -10.8% | 3.38% | 13.59倍 | 0.60倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック（後発医薬品）メーカー向け強い |
| 富士製薬 | 125,500円 | +15.7% | +5.3% | 3.63% | 9.07倍 | 0.67倍 |
|
女性医療、急性期医療の２領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
| ヘリオス | 21,900円 | +150.0% | - | 0.00% | - | 10.75倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| 扶桑薬 | 212,500円 | +8.3% | +98.1% | 3.86% | 6.99倍 | 0.48倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
市場注目の銘柄
チャート関連のコラム
